NUVB

Nuvation Bio Inc. Healthcare - Biotechnology Investor Relations →

NO
106.8% ABOVE
↑ Moving away Was 90.2% last week
-15% -10% -5% 0% 5% 10% 15%+
Buy Threshold $2.76
14-Week RSI 52

Nuvation Bio Inc. (NUVB) closed at $5.70 as of 2026-02-02, trading 106.8% above its 200-week moving average of $2.76. The stock moved further from the line this week, up from 90.2% last week. The 14-week RSI sits at 52, indicating neutral momentum.

Over the past 236 weeks of data, NUVB has crossed below its 200-week moving average 1 time. On average, these episodes lasted 212 weeks. The average one-year return after crossing below was -70.5%, suggesting these dips have not historically been reliable buying opportunities for this stock.

With a market cap of $1954 million, NUVB is a small-cap stock. Free cash flow yield is currently negative, meaning the company is burning cash. Return on equity stands at -52.5%. The stock trades at 6.0x book value.

Share count has increased 55.0% over three years, indicating dilution.

Over the past 4.6 years, a hypothetical investment of $100 in NUVB would have grown to $58, compared to $163 for the S&P 500. NUVB has returned -11.3% annualized vs 11.2% for the index, underperforming the broader market over this period.

Free cash flow has been declining. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.

Growth of $100: NUVB vs S&P 500

Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.

What Happens After NUVB Crosses Below the Line?

Across 1 historical episodes, buying NUVB when it crossed below its 200-week moving average produced an average return of -70.0% after 12 months (median -70.0%), compared to -11.0% for the S&P 500 over the same periods. After 24 months, the average return was -83.0% vs +3.0% for the index.

Each line shows $100 invested at the moment NUVB crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.

Advertisement

Historical Touches

NUVB has crossed below its 200-week MA 1 time with an average 1-year return of +-70.5% after recovery.

Crossed BelowRecoveredWeeksMax Depth1-Year ReturnReturn Since Touch
Aug 2021Aug 202521282.9%-70.5%-32.5%
Average212+-70.5%

Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.

Data as of Friday close, 2026-02-02